AstraZeneca COVID drug neutralizes Omicron sub-variants in lab study
This is the first data looking at the impact of AstraZeneca’s Evusheld treatment on “cousins” of the Omicron variant following a recent global spike in cases.
Stay updated with breaking news from Astrazeneca Evusheld. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This is the first data looking at the impact of AstraZeneca’s Evusheld treatment on “cousins” of the Omicron variant following a recent global spike in cases.
(Reuters) - Here's what you need to know about the coronavirus right now: Shanghai's Disney resort shut amid record daily local infections China's fin...
Approval is significant as waning restrictions present significant threats to many immunocompromised people across the UK - News - PharmaTimes
America Letter: As cases threaten to rise, release of funds falls prey to partisan politics
WASHINGTON (dpa-AFX) - Senior Biden administration officials have outlined the dire consequences that a lack of Covid-19 response funding will have on the United States if Congress fails to act.In